Cargando…
Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK
Microbial resistance to antibiotics is a serious global health problem compounded by antibiotic overuse and limited investment in new antibiotic research. Inappropriate perinatal antibiotic exposure is increasingly linked to lifelong adverse outcomes through its impact on the developing microbiome....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942449/ https://www.ncbi.nlm.nih.gov/pubmed/29756072 http://dx.doi.org/10.1136/bmjoq-2017-000285 |
_version_ | 1783321473840054272 |
---|---|
author | Makri, Vasiliki Davies, Gemma Cannell, Stephanie Willson, Katherine Winterson, Lucy Webb, Joanna Kandhari, Amit Mansour, Maha Thomas, Joanne Morris, Geraint Matthes, Jean Banerjee, Sujoy |
author_facet | Makri, Vasiliki Davies, Gemma Cannell, Stephanie Willson, Katherine Winterson, Lucy Webb, Joanna Kandhari, Amit Mansour, Maha Thomas, Joanne Morris, Geraint Matthes, Jean Banerjee, Sujoy |
author_sort | Makri, Vasiliki |
collection | PubMed |
description | Microbial resistance to antibiotics is a serious global health problem compounded by antibiotic overuse and limited investment in new antibiotic research. Inappropriate perinatal antibiotic exposure is increasingly linked to lifelong adverse outcomes through its impact on the developing microbiome. Antibiotic stewardship may be the only effective preventative strategy currently available. As the first tertiary neonatal unit in the UK to collaborate in an international quality improvement programme (QIP) with Vermont Oxford Network (VON), we present the results of our antibiotic stewardship initiative. The QIP was officially launched in January 2016 and aimed to reduce antibiotic usage rate (AUR) by 20% of baseline by 31st December 2016 without compromising patient safety. A multidisciplinary team of professionals and parent representatives shared good practices and improvement strategies through international webinars and local meetings, devised uniform data collection methodology and implemented a number of carefully selected ‘Plan–Do–Study–Act’ cycles. Run charts were used to present data and, where appropriate, statistical analysis undertaken to compare outcomes. The QIP resulted in a sustained reduction in AUR from a baseline median of 347 to 198 per 1000 patient-days (a reduction of 43%). The proportion of culture-negative sepsis screens where antibiotics were stopped within 36–48 hours increased consistently from a baseline of 32.5% to 91%. The antibiotic days per patient at discharge reduced from a median of 3 to 2 days, and there was a reduction in practice variation. Our annual mortality and necrotising enterocolitis rates for the VON cohort (<30 weeks or <1500 g) were the best ever recorded, 5.5% and 1.4%, respectively. Audits confirmed a high level of staff and family awareness of the QIP. The QIP achieved a sustained reduction in antibiotic use without compromising patient safety. Our challenge is to sustain this improvement safely. |
format | Online Article Text |
id | pubmed-5942449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-59424492018-05-11 Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK Makri, Vasiliki Davies, Gemma Cannell, Stephanie Willson, Katherine Winterson, Lucy Webb, Joanna Kandhari, Amit Mansour, Maha Thomas, Joanne Morris, Geraint Matthes, Jean Banerjee, Sujoy BMJ Open Qual BMJ Quality Improvement report Microbial resistance to antibiotics is a serious global health problem compounded by antibiotic overuse and limited investment in new antibiotic research. Inappropriate perinatal antibiotic exposure is increasingly linked to lifelong adverse outcomes through its impact on the developing microbiome. Antibiotic stewardship may be the only effective preventative strategy currently available. As the first tertiary neonatal unit in the UK to collaborate in an international quality improvement programme (QIP) with Vermont Oxford Network (VON), we present the results of our antibiotic stewardship initiative. The QIP was officially launched in January 2016 and aimed to reduce antibiotic usage rate (AUR) by 20% of baseline by 31st December 2016 without compromising patient safety. A multidisciplinary team of professionals and parent representatives shared good practices and improvement strategies through international webinars and local meetings, devised uniform data collection methodology and implemented a number of carefully selected ‘Plan–Do–Study–Act’ cycles. Run charts were used to present data and, where appropriate, statistical analysis undertaken to compare outcomes. The QIP resulted in a sustained reduction in AUR from a baseline median of 347 to 198 per 1000 patient-days (a reduction of 43%). The proportion of culture-negative sepsis screens where antibiotics were stopped within 36–48 hours increased consistently from a baseline of 32.5% to 91%. The antibiotic days per patient at discharge reduced from a median of 3 to 2 days, and there was a reduction in practice variation. Our annual mortality and necrotising enterocolitis rates for the VON cohort (<30 weeks or <1500 g) were the best ever recorded, 5.5% and 1.4%, respectively. Audits confirmed a high level of staff and family awareness of the QIP. The QIP achieved a sustained reduction in antibiotic use without compromising patient safety. Our challenge is to sustain this improvement safely. BMJ Publishing Group 2018-05-07 /pmc/articles/PMC5942449/ /pubmed/29756072 http://dx.doi.org/10.1136/bmjoq-2017-000285 Text en © Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | BMJ Quality Improvement report Makri, Vasiliki Davies, Gemma Cannell, Stephanie Willson, Katherine Winterson, Lucy Webb, Joanna Kandhari, Amit Mansour, Maha Thomas, Joanne Morris, Geraint Matthes, Jean Banerjee, Sujoy Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK |
title | Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK |
title_full | Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK |
title_fullStr | Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK |
title_full_unstemmed | Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK |
title_short | Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK |
title_sort | managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the uk |
topic | BMJ Quality Improvement report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942449/ https://www.ncbi.nlm.nih.gov/pubmed/29756072 http://dx.doi.org/10.1136/bmjoq-2017-000285 |
work_keys_str_mv | AT makrivasiliki managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT daviesgemma managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT cannellstephanie managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT willsonkatherine managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT wintersonlucy managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT webbjoanna managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT kandhariamit managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT mansourmaha managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT thomasjoanne managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT morrisgeraint managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT matthesjean managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk AT banerjeesujoy managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk |